metronidazole has been researched along with isotretinoin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Grosshans, E | 1 |
| Fearfield, LA; Simpson-Dent, S; Staughton, RC | 1 |
| Thiboutot, DM | 1 |
| Choudhary, S; Elsaie, ML | 1 |
| Cervigón, I; Palomo, A; Torres-Iglesias, LM | 1 |
| Gross, H | 1 |
| Cozzani, E; Drago, F; Gallo, R; Paolino, S; Parodi, A | 2 |
| Asai, Y; Baibergenova, A; Barankin, B; Cochrane, CL; Humphrey, S; Lynde, CW; Marcoux, D; Poulin, Y; Rivers, JK; Sapijaszko, M; Sibbald, RG; Tan, J; Toole, J; Ulmer, M; Zip, C | 1 |
| Gonser, L; Schaller, M | 1 |
| Aluri, S; Atrott, K; Becker, E; Bengs, S; Castro, PAR; Frey-Wagner, I; Opitz, L; Rogler, G; Stanzel, C | 1 |
| Chong, AH; Maor, D | 1 |
| Atrott, K; Becker, E; Bengs, S; Biedermann, L; Frey-Wagner, I; Jonas, D; Opitz, L; Poveda, L; Rehman, A; Rogler, G; Schmidt, TSB; Stanzel, C; von Mering, C | 1 |
| Bakos, RM; Kalil, CLPV; Prieto Herman Reinehr, C | 1 |
| Al-Niaimi, F; Ali, FR; Searle, T | 1 |
| Cline, A; Gomolin, T; Pereira, F | 1 |
6 review(s) available for metronidazole and isotretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acne and rosacea. New and emerging therapies.
Topics: Acne Vulgaris; Aged; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Isotretinoin; Metronidazole; Middle Aged; Retinoids; Rosacea | 2000 |
Updates on the pathophysiology and management of acne rosacea.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Metronidazole; Phototherapy; Rosacea; Sulfacetamide | 2009 |
Canadian Clinical Practice Guidelines for Rosacea.
Topics: Anti-Infective Agents; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Eye Diseases; Humans; Intense Pulsed Light Therapy; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Outliers, DRG; Practice Guidelines as Topic; Rosacea; Tetracycline | 2016 |
Perioral dermatitis: Diagnosis, proposed etiologies, and management.
Topics: Anti-Bacterial Agents; Dermatitis, Perioral; Dermatologic Agents; Humans; Isotretinoin; Metronidazole | 2021 |
Treatment of rosacea during pregnancy.
Topics: Adult; Algorithms; Animals; Anti-Bacterial Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Isotretinoin; Ivermectin; Metronidazole; Mice; Minocycline; Phototherapy; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosacea; Tetracyclines; Treatment Outcome | 2021 |
1 trial(s) available for metronidazole and isotretinoin
| Article | Year |
|---|---|
[Rosacea].
Topics: Body Temperature; Clinical Trials as Topic; Clonidine; Female; Humans; Isotretinoin; Male; Metronidazole; Naloxone; Rosacea; Tetracyclines | 1988 |
16 other study(ies) available for metronidazole and isotretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
HIV associated eosinophilic folliculitis--differential diagnosis and management.
Topics: Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Eosinophilia; Folliculitis; Glucocorticoids; Histamine H1 Antagonists; HIV Infections; Humans; Insecticides; Isotretinoin; Itraconazole; Keratolytic Agents; Metronidazole; Permethrin; Pyrethrins; Skin Diseases; Ultraviolet Therapy | 1999 |
[Symptomatic perioral, perinasal, and periocular papules].
Topics: Child; Dermatitis, Perioral; Diagnosis, Differential; Facial Dermatoses; Female; Granuloma; Humans; Isotretinoin; Metronidazole; Skin Diseases, Papulosquamous; Tetracycline | 2009 |
[Sunscreen, antibiotics, laser. What can you do against rosacea?].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Contraindications; Dermatologic Agents; Doxycycline; Female; Humans; Isotretinoin; Laser Therapy; Male; Metronidazole; Rhinophyma; Rosacea; Sunscreening Agents | 2009 |
[Treatment of rosacea].
Topics: Adapalene; Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Metronidazole; Mite Infestations; Naphthalenes; Rosacea; Sulfacetamide; Tacrolimus; Tetracycline; Toluidines; Tretinoin | 2011 |
Treatment of rosacea.
Topics: Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Lasers, Dye; Metronidazole; Mite Infestations; Naphthalenes; Phototherapy; Rosacea; Sulfacetamide; Tacrolimus; Tetracycline; Toluidines; Tretinoin | 2011 |
A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Isotretinoin; Metronidazole; Prednisolone; Rosacea | 2016 |
Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells?
Topics: Animals; Doxycycline; Epigenesis, Genetic; Female; Gene Expression Profiling; Isotretinoin; Metronidazole; Mice; Mice, Inbred BALB C; MicroRNAs; RNA, Messenger; T-Lymphocytes, Regulatory | 2016 |
Rosacea.
Topics: Anti-Bacterial Agents; Brimonidine Tartrate; Diagnosis, Differential; Doxycycline; Humans; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Rosacea | 2017 |
Effects of oral antibiotics and isotretinoin on the murine gut microbiota.
Topics: Animals; Anti-Bacterial Agents; Cluster Analysis; Dermatologic Agents; DNA, Ribosomal; Doxycycline; Female; Gastrointestinal Microbiome; Isotretinoin; Metronidazole; Mice, Inbred BALB C; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2017 |
Unusual case of rosacea fulminans after topical metronidazole application.
Topics: Administration, Cutaneous; Adult; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Isotretinoin; Metronidazole; Necrosis; Prednisolone; Rosacea; Skin; Treatment Outcome | 2019 |